BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36481267)

  • 1. Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa.
    Sabat R; Šimaitė D; Gudjonsson JE; Brembach TC; Witte K; Krause T; Kokolakis G; Bartnik E; Nikolaou C; Rill N; Coulibaly B; Levin C; Herrmann M; Salinas G; Leeuw T; Volk HD; Ghoreschi K; Wolk K
    J Allergy Clin Immunol; 2023 Apr; 151(4):1015-1026. PubMed ID: 36481267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa.
    Wolk K; Brembach TC; Šimaitė D; Bartnik E; Cucinotta S; Pokrywka A; Irmer ML; Triebus J; Witte-Händel E; Salinas G; Leeuw T; Volk HD; Ghoreschi K; Sabat R
    Br J Dermatol; 2021 Jul; 185(1):164-176. PubMed ID: 33400270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytotherapeuthics Affecting the IL-1/IL-17/G-CSF Axis: A Complementary Treatment Option for Hidradenitis Suppurativa?
    Witte K; Sabat R; Witte-Händel E; Ghoreschi K; Wolk K
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa.
    Gamell C; Bankovacki A; Scalzo-Inguanti K; Sedgmen B; Alhamdoosh M; Gail E; Turkovic L; Millar C; Johnson L; Wahlsten M; Richter J; Schuster J; Dyson A; Nicolopoulos J; Varigos G; Ng M; Wilson N; Field J; Kern JS; Lindqvist LM
    Br J Dermatol; 2023 Apr; 188(5):636-648. PubMed ID: 36691791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.
    Alexaki VI; Pelekanou V; Notas G; Venihaki M; Kampa M; Dessirier V; Sabour-Alaoui S; Stathopoulos EN; Tsapis A; Castanas E
    Endocrinology; 2012 Feb; 153(2):739-49. PubMed ID: 22166983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa/hidradenitis suppurativa.
    Wolk K; Wenzel J; Tsaousi A; Witte-Händel E; Babel N; Zelenak C; Volk HD; Sterry W; Schneider-Burrus S; Sabat R
    Br J Dermatol; 2017 Nov; 177(5):1385-1393. PubMed ID: 28256718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression.
    Navrazhina K; Garcet S; Zheng X; Hur HB; Frew JW; Krueger JG
    J Allergy Clin Immunol; 2022 Jan; 149(1):135-144.e12. PubMed ID: 34081946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa.
    Lowe MM; Cohen JN; Moss MI; Clancy S; Adler JP; Yates AE; Naik HB; Yadav R; Pauli M; Taylor I; McKay A; Harris H; Kim E; Hansen SL; Rosenblum MD; Moreau JM
    JCI Insight; 2024 Feb; 9(3):. PubMed ID: 38113104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils.
    Narla S; Azzam M; Townsend S; Vellaichamy G; Marzano AV; Alavi A; Lowes MA; Hamzavi IH
    Br J Dermatol; 2021 Jun; 184(6):1004-1013. PubMed ID: 32893875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-Depth Analysis of the Hidradenitis Suppurativa Serum Proteome Identifies Distinct Inflammatory Subtypes.
    Navrazhina K; Garcet S; Gonzalez J; Grand D; Frew JW; Krueger JG
    J Invest Dermatol; 2021 Sep; 141(9):2197-2207. PubMed ID: 33766512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions.
    van der Zee HH; de Ruiter L; Boer J; van den Broecke DG; den Hollander JC; Laman JD; Prens EP
    Br J Dermatol; 2012 Jan; 166(1):98-106. PubMed ID: 21929531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa.
    Navrazhina K; Frew JW; Gilleaudeau P; Sullivan-Whalen M; Garcet S; Krueger JG
    J Allergy Clin Immunol; 2021 Jun; 147(6):2213-2224. PubMed ID: 33548397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aetiology and pathogenesis of hidradenitis suppurativa.
    Wolk K; Join-Lambert O; Sabat R
    Br J Dermatol; 2020 Dec; 183(6):999-1010. PubMed ID: 33048349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocytes and immune cells in the epidermis are key drivers of inflammation in hidradenitis suppurativa providing a rationale for novel topical therapies.
    Schell SL; Cong Z; Sennett ML; Gettle SL; Longenecker AL; Goldberg SR; Kirby JS; Helm MF; Nelson AM
    Br J Dermatol; 2023 Feb; 188(3):407-419. PubMed ID: 36680309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris.
    Navrazhina K; Garcet S; Frew JW; Zheng X; Coats I; Guttman-Yassky E; Krueger JG
    J Am Acad Dermatol; 2022 Feb; 86(2):322-330. PubMed ID: 34339761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary alterations during the development of hidradenitis suppurativa.
    Dajnoki Z; Somogyi O; Medgyesi B; Jenei A; Szabó L; Gáspár K; Hendrik Z; Gergely P; Imre D; Póliska S; Törőcsik D; Zouboulis CC; Prens EP; Kapitány A; Szegedi A
    J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):462-471. PubMed ID: 34724272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa.
    Byrd AS; Carmona-Rivera C; O'Neil LJ; Carlucci PM; Cisar C; Rosenberg AZ; Kerns ML; Caffrey JA; Milner SM; Sacks JM; Aliu O; Broderick KP; Reichner JS; Miller LS; Kang S; Robinson WH; Okoye GA; Kaplan MJ
    Sci Transl Med; 2019 Sep; 11(508):. PubMed ID: 31484788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa.
    Lima AL; Karl I; Giner T; Poppe H; Schmidt M; Presser D; Goebeler M; Bauer B
    Br J Dermatol; 2016 Mar; 174(3):514-21. PubMed ID: 26436522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidradenitis suppurativa.
    González-López MA
    Med Clin (Barc); 2024 Feb; 162(4):182-189. PubMed ID: 37968174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.